![Mark C. Enright](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark C. Enright
Corporate Officer/Principal bei Imperial College London
Aktive Positionen von Mark C. Enright
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Imperial College London | Corporate Officer/Principal | 31.10.2011 | - |
Karriereverlauf von Mark C. Enright
Ehemalige bekannte Positionen von Mark C. Enright
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2011 | - |
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2011 | - |
Ausbildung von Mark C. Enright
University of Aberdeen | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Biocontrol Ltd. (United Kingdom)
![]() Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Mark C. Enright
- Erfahrung